Back to search
FDAFDA · Food and drugs·Recall number Z-2774-2024

Centurion procedure packs, containing Caina syringes, labeled as: 1) NICU CIRCUMCISION TRAY W/OUT CLAMP, Pack Number CIT6920; 2) RETINAL INJECTION KIT, Pack Number MNS12465

Published September 4, 2024 · Recall initiated: April 8, 2024

Summary

FDA records medical device Class II recall Z-2774-2024, published September 4, 2024 and initiated April 8, 2024. Recalling firm: MEDLINE INDUSTRIES, LP - Northfield; Status: Ongoing; Lot: CIT6920, Lot Number 2021092290; MNS12465, Lot Number 2022040190. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MEDLINE INDUSTRIES, LP - Northfield
Distributor
Worldwide distribution.
Lot
CIT6920, Lot Number 2021092290; MNS12465, Lot Number 2022040190
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Centurion procedure packs, containing Caina syringes, labeled as: 1) NICU CIRCUMCISION TRAY W/OUT CLAMP, Pack Number CIT6920; 2) RETINAL INJECTION KIT, Pack Number MNS12465 recalled?

Yes. FDA published recall Z-2774-2024 on September 4, 2024. Reported hazard: Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit